Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.42
-0.29 (-0.63%)
At close: Oct 5, 2026, 4:00 PM EDT
45.66
+0.23 (0.52%)
After-hours: Oct 5, 2026, 7:30 PM EDT
Spruce Biosciences Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Spruce Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $148. The average 1-year stock price forecast is 225.85% higher than the current stock price, while the lowest is $104 (+128.97%) and the highest is $230 (+406.38%).
Price Target: $148 (+225.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Spruce Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 6 | 7 | 7 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $140 | Buy | Maintains | $140 | +208.23% | Sep 30, 2026 |
| Lake Street | Lake Street | Buy Initiates $149 | Buy | Initiates | $149 | +228.05% | Sep 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $150 | Buy | Reiterates | $150 | +230.25% | Aug 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $230 | Buy | Reiterates | $230 | +406.38% | Aug 25, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $123 → $104 | Buy | Maintains | $123 → $104 | +128.97% | Aug 17, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
78.70M
EPS This Year
-25.32
from -50.83
EPS Next Year
4.98
from -25.32
EPS and Forward PE are based on non-GAAP adjusted numbers.